Clinical Trial Update: Fluoxetine to Prevent Relapse and Enhance Psychological Recovery in Women With Anorexia Nervosa [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating fluoxetine to prevent relapse and enhance psychological recovery in women with anorexia nervosa; results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anorexia Nervosa
• Eating Disorders

Drugs mentioned

• Fluoxetine (Fluoxetine)

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Anorexia Nervosa, Eating Disorders | Phase 4 | Status: COMPLETED | Results posted: 2016-07-11